Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (7): 607-609.DOI: 10.3969/j.issn.1673-8640.2017.07.011
• Orginal Article • Previous Articles Next Articles
Received:
2016-04-17
Online:
2017-08-08
Published:
2017-08-09
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.07.011
组别 | 例数 | 入院后 | 术前 | 术中 | 术后第1天 | 术后第3天 | 术后第5天 | χ2值 | P值 |
---|---|---|---|---|---|---|---|---|---|
并发 DVT组 | 17 | 5.79 (5.18~6.86) | 6.24 (5.70~6.89) | 9.03 (8.45~10.39) | 11.21 (9.98~12.62) | 11.39 (10.27~13.83) | 12.97 (10.47~14.89) | 83.552 | 0.00 |
未并发 DVT组 | 163 | 4.72 (0.81~5.58) | 4.62 (0.84~5.88) | 6.63 (2.34~7.66) | 6.29 (2.22~6.55) | 2.97 (0.64~3.65) | 0.73 (0.59~1.89) | 694.051 | 0.00 |
Z值 | 3.921 | 4.173 | 5.938 | 6.269 | 6.675 | 6.695 | |||
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | 入院后 | 术前 | 术中 | 术后第1天 | 术后第3天 | 术后第5天 | χ2值 | P值 |
---|---|---|---|---|---|---|---|---|---|
并发 DVT组 | 17 | 5.79 (5.18~6.86) | 6.24 (5.70~6.89) | 9.03 (8.45~10.39) | 11.21 (9.98~12.62) | 11.39 (10.27~13.83) | 12.97 (10.47~14.89) | 83.552 | 0.00 |
未并发 DVT组 | 163 | 4.72 (0.81~5.58) | 4.62 (0.84~5.88) | 6.63 (2.34~7.66) | 6.29 (2.22~6.55) | 2.97 (0.64~3.65) | 0.73 (0.59~1.89) | 694.051 | 0.00 |
Z值 | 3.921 | 4.173 | 5.938 | 6.269 | 6.675 | 6.695 | |||
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | 入院后 | 术前 | 术中 | 术后第1天 | 术后第3天 | 术后第5天 | χ2值 | P值 |
---|---|---|---|---|---|---|---|---|---|
骨盆组 | 40 | 6.25 (5.97~6.52) | 6.45 (6.29~6.55) | 7.78 (7.42~8.26) | 7.14 (6.56~7.93) | 3.84 (3.46~4.42) | 2.09 (1.89~2.43) | 114.484 | 0.000 |
脊柱组 | 40 | 5.34 (5.19~5.58) | 5.75 (5.60~5.91) | 7.76 (7.62~7.94) | 6.51 (6.41~6.62) | 3.11 (2.96~3.19) | 1.90 (1.85~2.03) | 116.386 | 0.000 |
上肢组 | 30 | 0.820 (0.79~0.85) | 0.85 (0.83~0.88) | 2.43 (2.28~2.64) | 2.29 (2.20~2.54) | 0.58 (0.51~0.66) | 0.52 (0.41~0.59) | 132.512 | 0.000 |
下肢组 | 40 | 4.70 (4.58~4.82) | 4.60 (4.49~4.85) | 6.62 (6.49~6.77) | 6.41 (6.21~6.55) | 6.34 (3.00~6.47) | 0.72 (0.68~0.84) | 124.536 | 0.000 |
手足组 | 30 | 0.64 (0.58~0.68) | 0.66 (0.61~0.73) | 1.79 (1.77~1.89) | 1.65 (1.59~1.69) | 0.63 (0.60~0.65) | 0.59 (0.55~0.62) | 117.563 | 0.000 |
H值 | 167.278 | 164.043 | 147.702 | 133.368 | 124.005 | 125.210 | |||
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
组别 | 例数 | 入院后 | 术前 | 术中 | 术后第1天 | 术后第3天 | 术后第5天 | χ2值 | P值 |
---|---|---|---|---|---|---|---|---|---|
骨盆组 | 40 | 6.25 (5.97~6.52) | 6.45 (6.29~6.55) | 7.78 (7.42~8.26) | 7.14 (6.56~7.93) | 3.84 (3.46~4.42) | 2.09 (1.89~2.43) | 114.484 | 0.000 |
脊柱组 | 40 | 5.34 (5.19~5.58) | 5.75 (5.60~5.91) | 7.76 (7.62~7.94) | 6.51 (6.41~6.62) | 3.11 (2.96~3.19) | 1.90 (1.85~2.03) | 116.386 | 0.000 |
上肢组 | 30 | 0.820 (0.79~0.85) | 0.85 (0.83~0.88) | 2.43 (2.28~2.64) | 2.29 (2.20~2.54) | 0.58 (0.51~0.66) | 0.52 (0.41~0.59) | 132.512 | 0.000 |
下肢组 | 40 | 4.70 (4.58~4.82) | 4.60 (4.49~4.85) | 6.62 (6.49~6.77) | 6.41 (6.21~6.55) | 6.34 (3.00~6.47) | 0.72 (0.68~0.84) | 124.536 | 0.000 |
手足组 | 30 | 0.64 (0.58~0.68) | 0.66 (0.61~0.73) | 1.79 (1.77~1.89) | 1.65 (1.59~1.69) | 0.63 (0.60~0.65) | 0.59 (0.55~0.62) | 117.563 | 0.000 |
H值 | 167.278 | 164.043 | 147.702 | 133.368 | 124.005 | 125.210 | |||
P值 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
[1] | 韦溦,杨星华,官正华,等. 血液流变学及血浆D-9二聚体对骨科大手术后发生深静脉血栓的诊断价值[J].中华创伤杂志,2013,29(8):782-784. |
[2] | JOVANOVIĆ M,MILIĆ D,DJINDJIĆ B,et al.Importance of D-dimer testing in ambulatory detection of atypical and "silent" phlebothrombosis[J].Vojnosanit Pregl,2010,67(7):543-547. |
[3] | 段秀群,尹良琼,龚国富. Wells评分联合D-二聚体检测在深静脉血栓诊断中的应用[J]. 检验医学,2016,31(7):581-583. |
[4] | 姜海峰,管世江. 骨折患者血清中D-二聚体的检测及其的临床意义[J]. 临床和实验医学杂志,2011,10(7):544-545. |
[5] | 侍冬成,吴蔚,赵钢,等. D-二聚体峰值变化与下肢骨折、骨盆骨折患者深静脉血栓的关系研究[J]. 重庆医学,2011,40(13):1291-1293. |
[6] | 禄婷婷. D-二聚体及纤维蛋白单体在骨科术后监测中的价值[J]. 检验医学,2016,31(8):681-683. |
[7] | 徐生根,毛兆光,朱慧华,等. 骨科大手术前后监测D-二聚体的意义[J]. 中国中西医结合外科杂志,2009,15(6):636-638. |
[8] | 李冬妹,区锦燕,刘晓捷.上肢创伤骨折与深静脉血栓的关系[J].当代医学,2012,18(18):38-39. |
[9] | 陈影秋,郭峰. D-二聚体对严重创伤的诊断价值[J].浙江创伤外科,2014,21(5):731-732. |
[10] | 安占天,穆亮,郝岩,等. D-二聚体水平的动态变化对脊柱骨折诱发深静脉血栓的临床意义[J]. 中国实用医刊,2015,42(1):26-27. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||